CHICAGO, February 1, 2011: Morgan Lewis today announced that David W. Clough-an intellectual property practitioner with nearly 18 years of experience and a PhD in microbiology, as well as the head of Howrey's Chicago office-has joined the firm as partner in its Intellectual Property practice, resident in Chicago. Paired with existing capabilities on the East and West coasts, as well as in Texas, Dr. Clough will strengthen the firm's ability to assist life sciences clients with their IP needs nationwide.
"Given the level of scientific innovation and competition in the areas of biologics and pharmaceuticals today, Dr. Clough is an ideal addition to our team," noted Kell M. Damsgaard, leader of the Intellectual Property Practice at Morgan Lewis. "His technical background and deep understanding of the challenges facing life sciences companies will be a tremendous resource for our clients."
Prior to becoming an attorney, Dr. Clough was as a Post-Doctoral Fellow in the Department of Microbiology and Molecular Genetics at the Harvard Medical School. Today, his law practice concentrates on the acquisition and enforcement of intellectual property rights worldwide and the design and implementation of global intellectual property strategies. He has represented clients before various courts and administrative agencies, and in private mediation and arbitration.
Dr. Clough has experience with a number of technologies, including gene therapy, genetically engineered viruses, cloning and expression of novel proteins, nucleic acid diagnostics, nucleic acid sequencing, transgenic animals, immunotherapies, immunocontraception, genetic engineering of antibodies, screening methods for identification of drug candidates, novel drug formulations and delivery systems, cancer therapy, food chemistry, steroid chemistry and biochemistry, genetically engineered plants and animals, methods and compositions for treating neurological diseases, and medical and surgical devices.